Investors

• Financial Results
• Investor Events
• Integrated Report
• Corporate Strategy
• ESG

• Oct. 13, 2026 InfoNotice Regarding Receipt of Warning Letter from FDA 
• Sep. 29, 2026 InfoNotice Regarding the Resignation of an Outside Director and a Change in the Composition of the Compensation Committee 
• Aug. 07, 2026 InfoFirst Quarter Financial Results for Fiscal Year 2027
• Jul. 17, 2026 InfoNotice Concerning Change of Executive Officer 
• Jun. 02, 2026 Info(Progress of disclosure matters) Notice Regarding Completion of Acquisition of BioProtect Ltd. 

View All

• Management Policies
  • Corporate Philosophy
  • Corporate Strategy
  • Top Management
  • Articles of Incorporation and Share Handling Regulations
  • Disclosure Policy
  • Business Risks
  • Company Presentation
• IR Library
  • Financial Results
  • Investor Events
  • Corporate Disclosure
  • Securities Reports
  • Integrated Report
  • Olympus Business
• Stock Information
  • Shareholders' Information
  • General Meeting of Shareholders
  • Shareholder Returns
  • Corporate Bonds and Ratings
  • Analyst Coverage
• Financial Data
  • Annual Data
  • Quarterly Data
  • Download Financial Data
• ESG
  • Olympus Group ESG
  • Environment
  • Social
  • Governance
• About Us
  • Olympus’ Value Creation Model
  • Fact Sheet
  • About Olympus

Annual Schedule

* The schedule may be subject to change.

• Bronze Award, Gomez IR Site Ranking operated by BroadBand Security, Inc. 
• Internet IR Commendation Award 2025 by Daiwa Investor Relations Co. Ltd.
• AAA Website, All Japanese Listed Companies' Website Ranking 2025, Overall and Sector by Nikko Investor Relations Co.,Ltd.